Copyright Reports & Markets. All rights reserved.

Global Small Molecule Drug CDMD Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Small Molecule Drug CDMD Services by Type
    • 1.3.1 Overview: Global Small Molecule Drug CDMD Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Small Molecule Drug CDMD Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Active Pharmaceutical Ingredients and Intermediates
    • 1.3.4 Finished Type
  • 1.4 Global Small Molecule Drug CDMD Services Market by Application
    • 1.4.1 Overview: Global Small Molecule Drug CDMD Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Business Use
    • 1.4.3 Academic Research
  • 1.5 Global Small Molecule Drug CDMD Services Market Size & Forecast
  • 1.6 Global Small Molecule Drug CDMD Services Market Size and Forecast by Region
    • 1.6.1 Global Small Molecule Drug CDMD Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Small Molecule Drug CDMD Services Market Size by Region, (2021-2032)
    • 1.6.3 North America Small Molecule Drug CDMD Services Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Small Molecule Drug CDMD Services Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Small Molecule Drug CDMD Services Market Size and Prospect (2021-2032)
    • 1.6.6 South America Small Molecule Drug CDMD Services Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Small Molecule Drug CDMD Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific Small Molecule Drug CDMD Services Product and Solutions
    • 2.1.4 Thermo Fisher Scientific Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Catalent
    • 2.2.1 Catalent Details
    • 2.2.2 Catalent Major Business
    • 2.2.3 Catalent Small Molecule Drug CDMD Services Product and Solutions
    • 2.2.4 Catalent Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Catalent Recent Developments and Future Plans
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza Small Molecule Drug CDMD Services Product and Solutions
    • 2.3.4 Lonza Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Lonza Recent Developments and Future Plans
  • 2.4 Asymchem
    • 2.4.1 Asymchem Details
    • 2.4.2 Asymchem Major Business
    • 2.4.3 Asymchem Small Molecule Drug CDMD Services Product and Solutions
    • 2.4.4 Asymchem Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Asymchem Recent Developments and Future Plans
  • 2.5 Delpharm
    • 2.5.1 Delpharm Details
    • 2.5.2 Delpharm Major Business
    • 2.5.3 Delpharm Small Molecule Drug CDMD Services Product and Solutions
    • 2.5.4 Delpharm Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Delpharm Recent Developments and Future Plans
  • 2.6 Aenova Group
    • 2.6.1 Aenova Group Details
    • 2.6.2 Aenova Group Major Business
    • 2.6.3 Aenova Group Small Molecule Drug CDMD Services Product and Solutions
    • 2.6.4 Aenova Group Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Aenova Group Recent Developments and Future Plans
  • 2.7 Siegfried Holding
    • 2.7.1 Siegfried Holding Details
    • 2.7.2 Siegfried Holding Major Business
    • 2.7.3 Siegfried Holding Small Molecule Drug CDMD Services Product and Solutions
    • 2.7.4 Siegfried Holding Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Siegfried Holding Recent Developments and Future Plans
  • 2.8 Recipharm AB
    • 2.8.1 Recipharm AB Details
    • 2.8.2 Recipharm AB Major Business
    • 2.8.3 Recipharm AB Small Molecule Drug CDMD Services Product and Solutions
    • 2.8.4 Recipharm AB Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Recipharm AB Recent Developments and Future Plans
  • 2.9 Fareva
    • 2.9.1 Fareva Details
    • 2.9.2 Fareva Major Business
    • 2.9.3 Fareva Small Molecule Drug CDMD Services Product and Solutions
    • 2.9.4 Fareva Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Fareva Recent Developments and Future Plans
  • 2.10 Almac
    • 2.10.1 Almac Details
    • 2.10.2 Almac Major Business
    • 2.10.3 Almac Small Molecule Drug CDMD Services Product and Solutions
    • 2.10.4 Almac Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Almac Recent Developments and Future Plans
  • 2.11 Cambrex
    • 2.11.1 Cambrex Details
    • 2.11.2 Cambrex Major Business
    • 2.11.3 Cambrex Small Molecule Drug CDMD Services Product and Solutions
    • 2.11.4 Cambrex Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Cambrex Recent Developments and Future Plans
  • 2.12 WuXi AppTec
    • 2.12.1 WuXi AppTec Details
    • 2.12.2 WuXi AppTec Major Business
    • 2.12.3 WuXi AppTec Small Molecule Drug CDMD Services Product and Solutions
    • 2.12.4 WuXi AppTec Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 WuXi AppTec Recent Developments and Future Plans
  • 2.13 Charles River
    • 2.13.1 Charles River Details
    • 2.13.2 Charles River Major Business
    • 2.13.3 Charles River Small Molecule Drug CDMD Services Product and Solutions
    • 2.13.4 Charles River Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Charles River Recent Developments and Future Plans
  • 2.14 CordenPharma
    • 2.14.1 CordenPharma Details
    • 2.14.2 CordenPharma Major Business
    • 2.14.3 CordenPharma Small Molecule Drug CDMD Services Product and Solutions
    • 2.14.4 CordenPharma Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 CordenPharma Recent Developments and Future Plans
  • 2.15 Jubilant Pharmova
    • 2.15.1 Jubilant Pharmova Details
    • 2.15.2 Jubilant Pharmova Major Business
    • 2.15.3 Jubilant Pharmova Small Molecule Drug CDMD Services Product and Solutions
    • 2.15.4 Jubilant Pharmova Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Jubilant Pharmova Recent Developments and Future Plans
  • 2.16 Pharmaron Inc.
    • 2.16.1 Pharmaron Inc. Details
    • 2.16.2 Pharmaron Inc. Major Business
    • 2.16.3 Pharmaron Inc. Small Molecule Drug CDMD Services Product and Solutions
    • 2.16.4 Pharmaron Inc. Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Pharmaron Inc. Recent Developments and Future Plans
  • 2.17 Porton
    • 2.17.1 Porton Details
    • 2.17.2 Porton Major Business
    • 2.17.3 Porton Small Molecule Drug CDMD Services Product and Solutions
    • 2.17.4 Porton Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Porton Recent Developments and Future Plans
  • 2.18 Jiuzhou Pharmaceutical
    • 2.18.1 Jiuzhou Pharmaceutical Details
    • 2.18.2 Jiuzhou Pharmaceutical Major Business
    • 2.18.3 Jiuzhou Pharmaceutical Small Molecule Drug CDMD Services Product and Solutions
    • 2.18.4 Jiuzhou Pharmaceutical Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Jiuzhou Pharmaceutical Recent Developments and Future Plans
  • 2.19 Zhejiang Apeloa
    • 2.19.1 Zhejiang Apeloa Details
    • 2.19.2 Zhejiang Apeloa Major Business
    • 2.19.3 Zhejiang Apeloa Small Molecule Drug CDMD Services Product and Solutions
    • 2.19.4 Zhejiang Apeloa Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Zhejiang Apeloa Recent Developments and Future Plans
  • 2.20 HwaGen
    • 2.20.1 HwaGen Details
    • 2.20.2 HwaGen Major Business
    • 2.20.3 HwaGen Small Molecule Drug CDMD Services Product and Solutions
    • 2.20.4 HwaGen Small Molecule Drug CDMD Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 HwaGen Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Small Molecule Drug CDMD Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Small Molecule Drug CDMD Services by Company Revenue
    • 3.2.2 Top 3 Small Molecule Drug CDMD Services Players Market Share in 2025
    • 3.2.3 Top 6 Small Molecule Drug CDMD Services Players Market Share in 2025
  • 3.3 Small Molecule Drug CDMD Services Market: Overall Company Footprint Analysis
    • 3.3.1 Small Molecule Drug CDMD Services Market: Region Footprint
    • 3.3.2 Small Molecule Drug CDMD Services Market: Company Product Type Footprint
    • 3.3.3 Small Molecule Drug CDMD Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Small Molecule Drug CDMD Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Small Molecule Drug CDMD Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Small Molecule Drug CDMD Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Small Molecule Drug CDMD Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Small Molecule Drug CDMD Services Consumption Value by Type (2021-2032)
  • 6.2 North America Small Molecule Drug CDMD Services Market Size by Application (2021-2032)
  • 6.3 North America Small Molecule Drug CDMD Services Market Size by Country
    • 6.3.1 North America Small Molecule Drug CDMD Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Small Molecule Drug CDMD Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Small Molecule Drug CDMD Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Small Molecule Drug CDMD Services Market Size by Country
    • 7.3.1 Europe Small Molecule Drug CDMD Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Small Molecule Drug CDMD Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Small Molecule Drug CDMD Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region
    • 8.3.1 Asia-Pacific Small Molecule Drug CDMD Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Small Molecule Drug CDMD Services Consumption Value by Type (2021-2032)
  • 9.2 South America Small Molecule Drug CDMD Services Consumption Value by Application (2021-2032)
  • 9.3 South America Small Molecule Drug CDMD Services Market Size by Country
    • 9.3.1 South America Small Molecule Drug CDMD Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Small Molecule Drug CDMD Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Small Molecule Drug CDMD Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country
    • 10.3.1 Middle East & Africa Small Molecule Drug CDMD Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Small Molecule Drug CDMD Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Small Molecule Drug CDMD Services Market Drivers
  • 11.2 Small Molecule Drug CDMD Services Market Restraints
  • 11.3 Small Molecule Drug CDMD Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Small Molecule Drug CDMD Services Industry Chain
  • 12.2 Small Molecule Drug CDMD Services Upstream Analysis
  • 12.3 Small Molecule Drug CDMD Services Midstream Analysis
  • 12.4 Small Molecule Drug CDMD Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Small Molecule Drug CDMD Services market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Small molecule drugs refer to relatively small organic molecules that usually enter the body through oral administration or other routes and are used to treat diseases. Small molecule drug services provided by Contract Development and Manufacturing Organizations (CDMOs) cover the entire drug development and manufacturing process.
    This report is a detailed and comprehensive analysis for global Small Molecule Drug CDMD Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Small Molecule Drug CDMD Services market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug CDMD Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug CDMD Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Small Molecule Drug CDMD Services market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Small Molecule Drug CDMD Services
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Small Molecule Drug CDMD Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB, Fareva, Almac, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Small Molecule Drug CDMD Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Active Pharmaceutical Ingredients and Intermediates
    Finished Type
    Market segment by Application
    Business Use
    Academic Research
    Market segment by players, this report covers
    Thermo Fisher Scientific
    Catalent
    Lonza
    Asymchem
    Delpharm
    Aenova Group
    Siegfried Holding
    Recipharm AB
    Fareva
    Almac
    Cambrex
    WuXi AppTec
    Charles River
    CordenPharma
    Jubilant Pharmova
    Pharmaron Inc.
    Porton
    Jiuzhou Pharmaceutical
    Zhejiang Apeloa
    HwaGen
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Small Molecule Drug CDMD Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Small Molecule Drug CDMD Services, with revenue, gross margin, and global market share of Small Molecule Drug CDMD Services from 2021 to 2026.
    Chapter 3, the Small Molecule Drug CDMD Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Small Molecule Drug CDMD Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Small Molecule Drug CDMD Services.
    Chapter 13, to describe Small Molecule Drug CDMD Services research findings and conclusion.

    Buy now